Whereas there are a number of cannabis-based companies and firms that dominate the market, there aren’t any doing what Jay Pharma is doing.

The mission of Jay Pharma is easy.

This Canadian-based firm desires to enhance the lives of individuals affected by most cancers by growing state-of-the-art cannabis-based merchandise and mixture therapies that target unmet wants in most cancers care.

CBD and the whole hashish trade are nonetheless so very new and never proof primarily based. The hashish trade itself is rather a lot just like the dot com trade within the early days.

There are loads of firms with excessive valuations however solely the businesses with a very good product will survive long run.

Desk of Contents

Ameri Holdings (Nasdaq: AMRH) to Merge with Jay Pharma

On January 13, Ameri Holdings introduced that they’d entered into an amalgamation settlement with Jay Pharma.

We sat in on a convention name on January 16 to see precisely what this may entail. The replay of the convention name is offered at +1 412-317-0088 with passcode 10138473.

The aim of the convention name was to debate how Ameri Holdings has entered into the amalgamation settlement whereby the shareholders of Jay Pharma will develop into the bulk holders of Ameri Holdings excellent inventory.

The truth that CBD and the whole hashish trade are nonetheless very new and never proof primarily based was largely mentioned.

That is the place the chance is.

Proof-based CBD merchandise that may be prescribed by oncologists or that have been accessible over-the-counter would change the trade ceaselessly.

There have already been extraordinarily constructive adjustments within the trade at massive. The passing of the 2018 Farm Invoice, legalization of leisure hashish in Canada, and the FDA approval of GW Pharma’s Epidiolex are monumental steps within the hashish trade.

Hashish and Most cancers Care

Medical doctors are requested on a regular basis by nearly all of their most cancers sufferers about cannabinoid-based medicines that might assist enhance their most cancers care.

The issue is, docs solely need to use evidence-based merchandise and there’s at present an absence of those merchandise within the trade.

That is one thing Jay Pharma desires to vary.

Dave Johnson, who is about to step into the position of Jay Pharma Chairman and CEO had the next to say:

“In accordance with a 2018 survey of 237 medical oncologists, 80% of oncologists focus on medical hashish with sufferers and practically one-half suggest it clinically. Critically, solely 30% of oncologists really feel sufficiently knowledgeable to make suggestions concerning medical hashish, suggesting a big unmet alternative to coach oncologists and supply analysis that helps the protection of medical hashish. In a market that’s extremely underdeveloped with little scientific knowledge, Jay Pharma has the potential to face aside as a developer of cannabinoid-based therapies completely centered on the wants of most cancers sufferers.”

The Way forward for Jay Pharma

To this point, the corporate has filed plenty of patents regarding using varied cannabinoids for particular kinds of most cancers and present most cancers therapies.

Initially, Jay Pharma plans to develop cannabinoid merchandise for these affected by most cancers and the unintended effects of most cancers therapy. Their long-term imaginative and prescient is the event of a channel of revolutionary mixture therapies that can be utilized along with customary most cancers care therapies, resembling chemotherapy and radiation.

To develop these merchandise and mixture therapies, Jay Pharma plans to make use of proprietary affected person knowledge that can assist information product growth and therapy planning.

By way of their strategy to the event of pharmaceutical and over-the-counter merchandise, they intend to take care of the wants of sufferers, docs and physicians, regulators, and high-value market section traders the place an evidence-based strategy to cannabinoid drugs is remitted.

They plan to do that in partnership with main researchers.

Jay Pharma Companions

Devoted to offering the highest-quality merchandise and mixture therapies, Jay Pharma has partnered with firms and analysis institutes they consider “have the potential to speed up pharmaceutical efforts, market entry, knowledge assortment, and evaluation.”

Considered one of these companions is Tikun Olam, Israel’s main medical hashish provider and one of many world’s largest, research-focused medical hashish firms.

Tikun Olam is dedicated to offering evidence-based hashish drugs and their merchandise have been used within the examine of a number of medical trials. Their database consists of over 12,000 folks which were handled for quite a lot of completely different situations, with a central deal with most cancers.

Jay Pharma will make use of using a proprietary hashish pressure generally known as Avidekel, a pressure developed by Tikun Olam with excessive CBD concentrations (18-30%) and low THC (<1%).

Avidekel was licensed to Jay Pharma for the event of OTC and pharmaceutical merchandise that shall be designed particularly for most cancers sufferers.

St. George’s College of London is one other Jay Pharma companion, which brings analysis expertise and related area data regarding CBD and most cancers.

They’ve additionally partnered with the Soroka College Medical Most cancers Middle, providing scientific analysis capabilities and in depth affected person entry.

Summary of Soroka Medical Center Study Data

Jay Pharma and Cannabinoid-Most cancers Care

Jay Pharma highlights that there’s an rising physique of proof suggesting CBD might have therapeutic, anti-tumor properties in regard to sure kinds of most cancers when used alone or together with present therapies.

Utilizing CBD in Conjunction with Most cancers Therapies

Pointing to preclinical knowledge that implies some mixture therapies might enhance sure chemotherapies or most cancers immunotherapies, Jay Pharma is at present working to develop revolutionary mixtures of CBD used along with chemotherapy and immunotherapy most cancers therapies.

Whereas conscious that historically hashish has been used to assist signs of most cancers therapies attributable to its appetite-stimulating, analgesic, and anti-emetic properties, Jay Pharma can be interested by cannabinoid therapies for his or her potential anti-tumor impact.

Citing research suggesting certain natural occurring cannabinoids have a therapeutic, anti-tumor effect, Jay Pharma believes that CBD mixture therapies have the chance to dramatically enhance outcomes in at-risk sufferers.

In addition they be aware that there’s proof to counsel that using CBD in conjunction with chemotherapy and different particular compounds may very well be more practical than utilizing CBD alone.

Relating to immunotherapy, Jay Pharma notes that preclinical research means that CBD could improve the power of dendritic cells to supply a cytokine may improve the immune system’s response towards sure cancers.

CBD and Most cancers Analysis Research

On their web site, Jay Pharma has included quite a few research concerning CBD/most cancers analysis. They provide a number of research on background analysis that has been accomplished on cannabinoids and their position in most cancers, together with pre-clinical and clinical assessments of cannabinoids as anti-cancer agents.

Anybody interested by studying extra concerning the varied research that think about cannabinoids the position they might play in most cancers is inspired to visit the database of related studies on Jay Pharma’s website.

Radiodermatitis

Radiodermatitis is among the commonest unintended effects of radiation, effecting some 95% of people that bear this aggressive most cancers therapy. It could actually range from a very gentle case of redness on the pores and skin to excessive circumstances the place pores and skin turns into extraordinarily painful and should bleed, crack, and blister.

Jay Pharma is at present operating preclinical trials with a cannabinoid-infused topical ointment. They be aware that apart from the protection profile of CBD, it additionally acts to average signs related to radiodermatitis, together with ache, irritation, wound therapeutic, and oxidative stress.

A number of examples of scientific knowledge that assist CBD’s capability to disrupt the growth and signs of radiodermatitis are included on Jay Pharma’s web site.

Info on the endocannabinoid system and its position in pores and skin homeostasis may also be discovered.

It shouldn’t be lengthy earlier than scientific trials are underway and Jay Pharma can start providing evidence-based CBD merchandise to those that want them most. When this happens, they may focus particularly on pores and skin situations, chemo induced nausea/vomiting, and power ache in sufferers with most cancers.

Featured Picture by Michal Jarmoluk from Pixabay

four.6 / 5 ( 10 votes )

CBD College Workers

Final Up to date on January 31, 2020